The GPR88 Agonist RTI‐122 Reduces Alcohol‐Related Motivation and Consumption
Addiction Biology · 2025
DOI: 10.1111/adb.70058 ↗Kurz gefasst
Fachartikel in der Zeitschrift Addiction Biology, 2025. Verfasst von Dennis F Lovelock und 12 weiteren Autor:innen. Beteiligte Einrichtung: Bowles Center for Alcohol Studies, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. Hauptthemen laut MEDLINE: Motivation, Receptors, G-Protein-Coupled, Alcohol Drinking. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDA NIH HHS, NIAAA NIH HHS, National Institute on Alcohol Abuse and Alcoholism.
Abstract (Originalsprache)
GPR88, an orphan G protein‐coupled receptor primarily expressed in the striatum, has emerged as a potential target for treating alcohol use disorder (AUD) due to its role in modulating reward and motivational pathways. In this study, we investigated the effects of the GPR88 agonist RTI‐122 on alcohol intake and motivation to self‐administer alcohol under different conditions. In mice, RTI‐122 reduced alcohol consumption in a two‐bottle choice paradigm, which was prevented by Gpr88 knockout, confirming a GPR88‐specific effect on the attenuation of alcohol drinking. In rats, RTI‐122 dose‐dependently reduced operant alcohol self‐administration and decreased motivation to self‐administer alcohol in progressive ratio tasks, regardless of whether the alcohol was adulterated with quinine or not. Additionally, a high dose of RTI‐122 reduced yohimbine‐induced reinstatement. Importantly, RTI‐122 did not affect water intake in mice or sucrose self‐administration in rats, indicating receptor‐ and reward‐specific modulation of alcohol intake. These findings suggest that RTI‐122, through GPR88 agonism, effectively reduces alcohol consumption and motivation across various contexts, positioning it as a promising lead for the development of new AUD treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Bowles Center for Alcohol Studies, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
- INSERM UMR 1247, University of Picardie Jules Verne, Amiens, France.
- INSERM UMR-S 1329, Strasbourg Translational Neuroscience and Psychiatry, University of Strasbourg, Strasbourg, France.
- Center for Drug Discovery, Research Triangle Institute, Research Triangle Park, North Carolina, USA.
- Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
ORCID-Profile: Emmanuel Darcq, Md Toufiqur Rahman, Mickael Naassila, Brigitte L Kieffer, Chunyang Jin, Joyce Besheer
Förderung
- NIDA NIH HHS
- NIAAA NIH HHS
- National Institute on Alcohol Abuse and Alcoholism
Zitieren
APA
Lovelock, D. F., Liu, W., Hamida, S. B., Cordero, V. L., Van Voorhies, K. J., Martin, M., Olmo, I. G., Darcq, E., Rahman, M. T., Naassila, M., Kieffer, B. L., Jin, C., & Besheer, J. (2025). The GPR88 Agonist RTI‐122 Reduces Alcohol‐Related Motivation and Consumption. Addiction Biology. https://doi.org/10.1111/adb.70058
Vancouver
Lovelock DF, Liu W, Hamida SB, Cordero VL, Van Voorhies KJ, Martin M, et al. The GPR88 Agonist RTI‐122 Reduces Alcohol‐Related Motivation and Consumption. Addiction Biology. 2025. doi:10.1111/adb.70058
BibTeX
@article{Lovelock2025,
author = {Lovelock, Dennis F and Liu, Wen and Hamida, Sami Ben and Cordero, Victoria L and Van Voorhies, Kalynn J and Martin, Marion and Olmo, Isabella Guimaraes and Darcq, Emmanuel and Rahman, Md Toufiqur and Naassila, Mickael and Kieffer, Brigitte L and Jin, Chunyang and Besheer, Joyce},
title = {The GPR88 Agonist RTI‐122 Reduces Alcohol‐Related Motivation and Consumption},
journal = {Addiction Biology},
year = {2025},
doi = {10.1111/adb.70058}
}
EUVIMED